These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32361484)

  • 1. Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies.
    Pellacani C; Eleftheriou G
    Adv Med Sci; 2020 Sep; 65(2):265-285. PubMed ID: 32361484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced neurotoxicity: the value of neuroprotective strategies.
    Beijers AJ; Jongen JL; Vreugdenhil G
    Neth J Med; 2012 Jan; 70(1):18-25. PubMed ID: 22271810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.
    Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander M; Kiernan MC
    Curr Med Chem; 2008; 15(29):3081-94. PubMed ID: 19075655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches.
    Screnci D; McKeage MJ
    J Inorg Biochem; 1999 Oct; 77(1-2):105-10. PubMed ID: 10626361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
    Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
    Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced peripheral neurotoxicity: a critical analysis.
    Park SB; Goldstein D; Krishnan AV; Lin CS; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC
    CA Cancer J Clin; 2013; 63(6):419-37. PubMed ID: 24590861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced peripheral neurotoxicity.
    Cavaletti G; Marmiroli P
    Expert Opin Drug Saf; 2004 Nov; 3(6):535-46. PubMed ID: 15500413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
    Nakane M
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of oxaliplatin neurotoxicity by drugs in humans and experimental animals: a minireview of recent literature.
    Ali BH
    Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):272-9. PubMed ID: 20050845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.
    Verstappen CC; Heimans JJ; Hoekman K; Postma TJ
    Drugs; 2003; 63(15):1549-63. PubMed ID: 12887262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced neuropathies-a growing problem for patients and health care providers.
    Banach M; Juranek JK; Zygulska AL
    Brain Behav; 2017 Jan; 7(1):e00558. PubMed ID: 28127506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity.
    Carozzi VA; Marmiroli P; Cavaletti G
    Curr Cancer Drug Targets; 2010 Nov; 10(7):670-82. PubMed ID: 20578989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological predictors of chemotherapy-induced peripheral neuropathy (CIPN): MASCC neurological complications working group overview.
    Chan A; Hertz DL; Morales M; Adams EJ; Gordon S; Tan CJ; Staff NP; Kamath J; Oh J; Shinde S; Pon D; Dixit N; D'Olimpio J; Dumitrescu C; Gobbo M; Kober K; Mayo S; Pang L; Subbiah I; Beutler AS; Peters KB; Loprinzi C; Lustberg MB
    Support Care Cancer; 2019 Oct; 27(10):3729-3737. PubMed ID: 31363906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update.
    Argyriou AA; Bruna J; Marmiroli P; Cavaletti G
    Crit Rev Oncol Hematol; 2012 Apr; 82(1):51-77. PubMed ID: 21908200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-treatment-induced neurotoxicity--focus on newer treatments.
    Stone JB; DeAngelis LM
    Nat Rev Clin Oncol; 2016 Feb; 13(2):92-105. PubMed ID: 26391778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal drug transporters in platinum drugs-induced peripheral neurotoxicity.
    Cavaletti G; Ceresa C; Nicolini G; Marmiroli P
    Anticancer Res; 2014 Jan; 34(1):483-6. PubMed ID: 24403505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic neuropathy.
    Umapathi T; Chaudhry V
    Curr Opin Neurol; 2005 Oct; 18(5):574-80. PubMed ID: 16155443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum-induced neurotoxicity and preventive strategies: past, present, and future.
    Avan A; Postma TJ; Ceresa C; Avan A; Cavaletti G; Giovannetti E; Peters GJ
    Oncologist; 2015 Apr; 20(4):411-32. PubMed ID: 25765877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
    Kerckhove N; Busserolles J; Stanbury T; Pereira B; Plence V; Bonnetain F; Krakowski I; Eschalier A; Pezet D; Balayssac D
    BMJ Open; 2019 Jun; 9(6):e027770. PubMed ID: 31182448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central and peripheral nervous system toxicity of common chemotherapeutic agents.
    Sioka C; Kyritsis AP
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):761-7. PubMed ID: 19034447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.